<DOC>
	<DOCNO>NCT02239354</DOCNO>
	<brief_summary>The purpose trial test VC-01™ combination product implant subcutaneously subject Type 1 Diabetes maintain safely two year . It also test VC-01 effective treatment subject Type 1 Diabetes .</brief_summary>
	<brief_title>A Safety , Tolerability , Efficacy Study VC-01™ Combination Product Subjects With Type I Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Men woman ( nonpregnant nonchildbearing potential ) Diagnosis type 1 diabetes mellitus least 3 year Stable diabetic treatment Willingness use continuous glucose meter Acceptable candidate implantation Advanced complication associate diabetes Immunosuppressive therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>